Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma

Endocrine-Related Cancer

Volumn 21, Issue 3, 2014, Pages

  Kimura, Noriko ^a   Takekoshi, Kazuhiro ^b   Horii, Akira ^c   Morimoto, Ryo ^c   Imai, Tsuneo ^d   Oki, Yutaka ^e   Saito, Tomohito ^f   Midorikawa, Sanae ^g   Arao, Tadashi ^h   Sugisawa, Chiho ^h   Yamada, Masanobu ⁱ   Otuka, Yuichi ^j   Kurihara, Isao ^k   Sugano, Kokichi ^l   Nakane, Minoru ^m   Fukuuchi, Atsushi ⁿ   Kitamoto, Takumi ^o   Saito, Jun ^o   Nishikawa, Tetsuo ^o   Naruse, Mitsuhide ^p  

^a National Hospital Organization   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANSAI MEDICAL UNIVERSITY   (Japan)

^g FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^h UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

ⁱ GUNMA UNIVERSITY   (Japan)

^j Sapporo Medical Center   (Japan)

^k KEIO UNIVERSITY   (Japan)

^l NATIONAL CANCER CENTER   (Japan)

^m MUSASHINO RED CROSS HOSPITAL   (Japan)

ⁿ MITSUI MEMORIAL HOSPITAL   (Japan)

^o YOKOHAMA ROSAI HOSPITAL   (Japan)

^p NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOPAMINE; NORADRENALIN; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT B; UNCLASSIFIED DRUG; SDHB PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADRENAL GLAND; ADULT; BLADDER; CLINICAL ARTICLE; ENZYME SUBUNIT; FAMILY HISTORY; FEMALE; GERMLINE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAPANESE (PEOPLE); LETTER; MALE; MEDIASTINUM; METASTASIS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RETROPERITONEUM; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ADRENAL TUMOR; METABOLISM; PATHOLOGY; SECONDARY;

ADRENAL GLAND NEOPLASMS; FEMALE; HUMANS; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84903577999     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0530     Document Type: Letter

References (10)

1. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP et al. 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 3822-3828. (doi:10.1210/jc. 2007-0709)
2. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O et al. 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism 91 827-836. (doi:10.1210/jc.2005-1862) (Pubitemid 43357746)
3. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ et al. 2012 Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. European Journal of Cancer 48 1739-1749. (doi:10.1016/j.ejca.2011.07.016)
4. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X et al. 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research 63 5615-5621. (Pubitemid 37139886)
5. Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami E, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T et al. 2014 Pathologic grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocrine-Related Cancer 21 405-414. (doi:10.1530/ERC-14-0494)
6. van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H et al. 2009 An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncology 10 764-771. (doi:10.1016/S1470-2045(09)70164-0)
7. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA et al. 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951. (doi:10.1001/jama.292.8.943) (Pubitemid 39097204)
8. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW & Pacak K 2007 Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 779-786. (doi:10.1210/jc.2006-2315) (Pubitemid 46465640)
9. Welander J, Söderkvist P & Gimm O 2011 Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocrine-Related Cancer 18 R253-R276. (doi:10.1530/ERC-11-0170)
10. Young AL, Baysal BE, Deb A & Young WF Jr 2002 Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. Journal of Clinical Endocrinology and Metabolism 87 4101-4105. (doi:10.1210/jc.2002-020312)